Moderna stock rose Tuesday even after the Food and Drug Administration held off recommending a booster dose of the company's Covid shot.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting
- USA TODAY
So far, 8.8 million Americans have received a booster dose of the Pfizer vaccine. Here’s everything to know about booster doses of all three vaccines.
- Washington Examiner
The United Kingdom's drug regulatory agency added a rare autoimmune nerve disorder to its list of possible COVID-19 vaccine complications.
- The Telegraph
“Nothing happened.” Those were the first words I heard when I woke up in a strange bed, with nine hours of memory missing. The last thing I had known, a colleague and I were out for a drink. It was 8pm, still light out, and I remember thinking how great it was that it was early enough to make it to my friend’s house for dinner.
On Oct. 20, nearly a month after Pfizer booster shots were approved for at-risk groups, the FDA has officially authorized Moderna and Johnson & Johnson boosters.
- The Daily Beast
via TelegramNIZHNY NOVGOROD—A gut-wrenching video has been circulating in Russia showing a dead COVID-19 patient on his hospital bed in the town of Novouralsk, apparently neglected by nurses and doctors. In the clip, another patient—the man who posted the video—is seen running around the hospital’s empty hallways screaming at the top of his lungs in an effort to flag down medical staff to tend to the deceased. “Girls, anybody?! Nurses, doctors!,” he can be heard shouting. No one responds to his
- HuffPost Life
If you're questioning your immunity from your COVID shot or if you want to know your status before getting a booster, read this first.
Wall Street has mixed feelings about penny stocks. These tickers changing hands for less than $5 per share either draw investors in with their high return potential or send them running for the hills, but why? When we say high return potential, we aren’t exaggerating. The bargain price points allow investors to snap up more shares than possible when investing in other more well-known names. What’s more, even what feels like trivial share price appreciation can translate to massive percentage gai
Former U.S. president Bill Clinton addressed the public via Twitter for the first time since his recent hospitalization for a non-COVID-related infection
Pfizer and BioNTech say booster shots restored the vaccine's efficacy rate to 95.6%, according to a new clinical trial.
- Kansas City Star
About 19% of the unvaccinated people in Kansas and 15% of those in Missouri don’t believe COVID-19 is a threat.
- Women's Health
Many cold and COVID-19 symptoms are similar, including runny nose, sore throat, and cough. Here's how to tell the difference between the two.
- The Telegraph
Antiviral drugs that could halve the risk of death or hospitalisation from Covid could be given to hundreds of thousands of vulnerable patients under a new NHS deal.
“Medicare & You 2022” is four pages longer than the 2021 edition I received earlier this year, when I was turning age 65. Last time around, I spent many hours on the subject and, even then, I was just barely comfortable making my Medicare choice. All of you who hit 65 this year will also know that the “official U.S. government Medicare handbook” is among a mountain of mail you received from insurers, many hoping to sell you a Medigap or prescription drug policy.
- LA Times
Officials say it's possible to safely participate in many holiday activities if everyone is vaccinated for COVID. But extra precautions may be needed.
- LA Times
As more California cities require proof of COVID-19 vaccinations in public places, a cherished burger chain has become an unlikely flashpoint.
Something to consider this open enrollment season: Your vaccination status can have financial consequences
The CDC's influential vaccines advisory committee recommended both Pfizer and Merck’s new pneumococcal vaccines for older adults, surprising analysts.
- Business Insider
The FDA has approved mix-and-match boosters, allowing fully vaccinated people to get an extra dose of a different COVID-19 vaccine. Here's why.
- Business Insider
The results came from Pfizer's late stage COVID-19 booster trial. The results haven't yet been formally published or scrutinized by other experts.
- BuzzFeed News
Many people are now eligible for a COVID-19 vaccine booster shot. Here’s what you need to know about mix-and-match vaccines, boosters, and more.View Entire Post ›